Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.

Juliebø AT, Folseraas T, Karlsen TH, Boberg KM, International PSC Study Group (IPSCSG)

Open source

DOI
10.1016/j.jhep.2026.02.009
Published
2026 May
Container
Journal of hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2026.02.009,
  title = {Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.},
  author = {Juliebø AT and Folseraas T and Karlsen TH and Boberg KM and International PSC Study Group (IPSCSG)},
  year = {2026},
  journal = {Journal of hepatology},
  doi = {10.1016/j.jhep.2026.02.009},
  url = {https://doi.org/10.1016/j.jhep.2026.02.009}
}

RIS

TY  - JOUR
TI  - Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.
AU  - Juliebø AT
AU  - Folseraas T
AU  - Karlsen TH
AU  - Boberg KM
AU  - International PSC Study Group (IPSCSG)
PY  - 2026
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2026.02.009
UR  - https://doi.org/10.1016/j.jhep.2026.02.009
ER  - 

APA

AT, J., T, F., TH, K., KM, B., & (IPSCSG), I. P. S. G. (2026). Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.. Journal of hepatology. https://doi.org/10.1016/j.jhep.2026.02.009

Source records